Tonix Pharmaceuticals Holding Corp. Annual report pursuant to Section 13 and 15(d)

The Series A Preferred Stock and Series B Preferred Stock was recorded at redemption value (Details)

The Series A Preferred Stock and Series B Preferred Stock was recorded at redemption value (Details) - USD ($) $ in Thousands	Oct. 26, 2022	Jun. 24, 2022
Series A Preferred Stock [Member]
Gross Proceeds	$ 13,300	$ 23,750
Preferred stock issuance costs	(844)	(1,046)
Accretion of carrying value to redemption value	2,244	3,546
Preferred stock subject to possible redemption	14,700	26,250
Series B Preferred Stock [Member]
Gross Proceeds	950	4,750
Preferred stock issuance costs	(60)	(209)
Accretion of carrying value to redemption value	160	709
Preferred stock subject to possible redemption	$ 1,050	$ 5,250

- Definition

Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.

+ References + Details